Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb 19:8:18.
doi: 10.1186/1479-5876-8-18.

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders

Affiliations

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders

Luigi Buonaguro et al. J Transl Med. .

Abstract

Hepatitis C virus (HCV) is one of the major risk factors for chronic hepatitis, which may progress to cirrhosis and hepatocellular carcinoma, as well as for type II mixed cryoglobulinemia (MC), which may further evolve into an overt B-cell non-Hodgkin's lymphoma (NHL). It has been previously shown that B-cell receptor (BCR) repertoire, expressed by clonal B-cells involved in type II MC as well as in HCV-associated NHL, is constrained to a limited number of variable heavy (VH)- and light (VL)-chain genes. Among these, the VK3-20 light chain idiotype has been selected as a possible target for passive as well as active immunization strategy. In the present study, we describe the results of a multiparametric analysis of the innate and early adaptive immune response after ex vivo stimulation of human immune cells with the VK3-20 protein. This objective has been pursued by implementing high-throughput technologies such as multiparameter flow cytometry and multiplex analysis of cytokines and chemokines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PBMCs were incubated with increasing doses of VK3-20 protein for 16 hrs. The expression of CD83, CD86 and HLADR was analysed by FACScalibur flow cytometer in CD14+ monocytes, CD123+ pDCs and CD11c+ mDCs. Data analysis was carried out with WinMDI2.8 Software. One representative experiment is shown.
Figure 2
Figure 2
Comparative analysis of the expression of surface maturation/activation markers (CD83, CD86, HLADR) performed on stimulated MDDCs, CD123+ pDCs and CD11c+ mDCs.
Figure 3
Figure 3
6-color flow cytometric analysis was performed on VK3-20 protein-stimulated monocytes, mDC/pDC cell populations and immunophenotype analysis of surface maturation/activation marker expression is shown. Values in each quadrant represent the percentage of positive cells.
Figure 4
Figure 4
Basal level expression of surface maturation/activation markers, indicated as Mean Fluorescence Index (MFI), on PBMC-derived monocytes and DC from control and HCV positive (HCV+) subjects. CD14 = CD14+ monocytes; CD123 = CD123+ pDCs; CD11c = CD11c+ mDCs.
Figure 5
Figure 5
Expression of surface maturation/activation markers, indicated as Mean Fluorescence Index (MFI), induced by the indicated concentrations of VK3-20 and LPS in PBMC-derived monocytes and DC from control subjects. CD14 = CD14+ monocytes; CD123 = CD123+ pDC; CD11c = CD11c+ mDC.
Figure 6
Figure 6
Expression of surface maturation/activation markers, indicated as Mean Fluorescence Index (MFI), induced by the indicated concentrations of VK3-20 and LPS in PBMC-derived monocytes and DC from HCV seropositive subjects. CD14 = CD14+ monocytes; CD123 = CD123+ pDC; CD11c = CD11c+ mDC.
Figure 7
Figure 7
Analysis of basal level production of Th1 and Th2 cytokines in supernatants of PBMCs from control and HCV positive (HCV+) subjects.
Figure 8
Figure 8
Analysis of Th1 and Th2 cytokines in supernatants of PBMCs from control subjects induced by the indicated concentrations of VK3-20 and LPS.
Figure 9
Figure 9
Analysis of Th1 and Th2 cytokines in supernatants of PBMCs from HCV seropositive subjects induced by the indicated concentrations of VK3-20 and LPS.

Similar articles

Cited by

References

    1. Moradpour D, Blum HE. Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17:477–483. doi: 10.1097/00042737-200505000-00002. - DOI - PubMed
    1. Ferri C, Caracciolo F, Zignego AL, La CL, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol. 1994;88:392–394. doi: 10.1111/j.1365-2141.1994.tb05036.x. - DOI - PubMed
    1. Ferri C, Longombardo G, La CL, Greco F, Lombardini F, Cecchetti R, Cagianelli MA, Marchi S, Monti M, Zignego AL. Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease. J Intern Med. 1994;236:31–36. doi: 10.1111/j.1365-2796.1994.tb01116.x. - DOI - PubMed
    1. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 1997;127:423–428. - PubMed
    1. De Re V, Caggiari L, Simula MP, De VS, Sansonno D, Dolcetti R. B-cell lymphomas associated with HCV infection. Gastroenterology. 2007;132:1205–1207. doi: 10.1053/j.gastro.2007.02.009. - DOI - PubMed

Publication types

MeSH terms